HDAC9 and amyotrophic lateral sclerosis: Furthermore, the HDAC inhibitory function of 4-PBA has also been studied in neurodegenerative diseases related to abnormal histone acetylation, such as Huntington's disease (HD) [79], amyotrophic lateral sclerosis (ALS) [80], and spinal muscular atrophy (SMA) [75].